Centerline Biomedical is raising its next round of funding through the RedCrow.com equity crowdfunding platform! Please visit our crowdfunding profile to learn more If you have any questions or would like…
Centerline Biomedical was recently chosen as one of Ohio’s top 50 most-promising startups, according to VentureOhio. VentureOhio aims to improve access to capital and foster collaboration in the startup community.
The Critical Issues in Aortic Endografting International Experts Symposium focuses on the the most pressing issues affecting minimally-invasive aortic repair
This summer Centerline Biomedical has partnered with Ohio Third Frontier as a part of their Diversity & Inclusion Technology Internship Program. This program is geared towards matching college students with early-stage technology companies to give them a real-world field related experience as well as business and entrepreneurial experiences.
Vascular disease is increasingly common, affecting millions of people in the U.S. Procedures to address vascular conditions are complex, risky and potentially harmful to patients—and even to the physicians who treat them.
Centerline Biomedical, a Cleveland Clinic spinoff, is part of this Wall Street Journal story about tech advances that are making the operating room “smarter, more effective — and a lot less risky for patients.”
Centerline Biomedical attended the 67th Congress of the European Society of Cardiovascular and Endovascular Surgery (ESCVS) from April 12th-14th.
Radiation dose optimization and safety associated with the use of fluoroscopy is increasingly being recognized as an issue.
Waiting for FDA clearance for your medical device can definitely feel like an eternity, but it’s important to be aware of what not to do during this process.
An aortic aneurysm is a potentially fatal disease that is caused by a weakening of the walls of the aorta. It was, for example, the cause of death for the famed physicist Albert Einstein.
Recent Comments